SynthesisEuropean journal of clinical pharmacology2022

Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies.

Bhavani Shankara Bagepally et al.PubMed ↗Publisher ↗

No numbers read from the abstract.